The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38
Abstract
Pituitary adenylate cyclase-activating polypeptide-38 (PACAP38) and vasoactive intestinal polypeptide are structurally and functionally closely related but show differences in migraine-inducing properties. Mechanisms responsible for the difference in migraine induction are unknown. Here, for the first time, we present a head-to-head comparison study of the immediate and long-lasting observations of the migraine-inducing, arterial, physiological and biochemical responses comparing PACAP38 and vasoactive intestinal polypeptide. In a double-blind crossover study 24 female migraine patients without aura were randomly allocated to intravenous infusion of PACAP38 (10 pmol/kg/min) or vasoactive intestinal polypeptide (8 pmol/kg/min) over 20 min. We recorded incidence of migraine during and after infusion (0-24 h). Magnetic resonance angiography of selected extra- and intracranial arteries, blood samples (plasma PACAP38 and vasoactive intestinal polypeptide and serum tryptase), and vital signs (blood pressure, heart rate, respiratory frequency, and end-tidal pressure of CO2) was recorded before and up to 5 h after infusion. Twenty-two patients [mean age 24 years (range 19-36)] completed the study on both days. Sixteen patients (73%) reported migraine-like attacks after PACAP38 and four after vasoactive intestinal polypeptide (18%) infusion (P = 0.002). Three of four patients, who reported migraine-like attacks after vasoactive intestinal polypeptide, also reported attacks after PACAP38. Both peptides induced marked dilatation of the extracranial (P < 0.05), but not intracranial arteries (P > 0.05). PACAP38-induced vasodilatation was longer lasting (>2 h), whereas vasoactive intestinal polypeptide-induced dilatation was normalized after 2 h. We recorded elevated plasma PACAP38 at 1 h after the start of PACAP38 infusion only in those patients who later reported migraine attacks. Blood levels of vasoactive intestinal polypeptide and tryptase were unchanged after PACAP38 infusion. In conclusion, PACAP38-induced migraine was associated with sustained dilatation of extracranial arteries and elevated plasma PACAP38 before onset of migraine-like attacks. PACAP38 has a much higher affinity for the PAC1 receptor and we therefore suggest that migraine induction by PACAP38 may be because of activation of the PAC1 receptor, which may be a future anti-migraine drug target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practical Statistics for Medical Research.
Walter, S. D., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,668
Practical Statistics for Medical Research
Altman, D. G. (1990) · doi:10.1201/9780429258589 · Cited by 10,668
Analysis of serial measurements in medical research.
Matthews, J. N., Altman, D. G., Campbell, M. J., & Royston, P. (1990) · BMJ · doi:10.1136/bmj.300.6719.230 · Cited by 3,136
The International Classification of Headache Disorders
Olesen, J. (2008) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01121.x · Cited by 2,321
Self-citationPRACTICAL STATISTICS FOR MEDICAL RESEARCH
Ludbrook, J. (1991) · Australian and New Zealand Journal of Surgery · doi:10.1111/j.1445-2197.1991.tb00019.x · Cited by 1,213
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
Vaudry, D., Falluel-Morel, A., Bourgault, S., Basille, M., Burel, D., Wurtz, O., Fournier, A., Chow, B. K. C., Hashimoto, H., Galas, L., et al. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001370 · Cited by 1,058
(1949) · Physical Therapy · doi:10.1093/ptj/29.4.190c · Cited by 800
The international classification of headache disorders
(2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.05.044 · Cited by 734
International Classification of Headache Disorders
Olesen, J. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30085-1 · Cited by 544
Self-citationPACAP38 induces migraine-like attacks in patients with migraine without aura
Schytz, H. W., Birk, S., Wienecke, T., Kruuse, C., Olesen, J., & Ashina, M. (2009) · Brain · doi:10.1093/brain/awn307 · Cited by 494
Self-citationHarmar, A. J., Fahrenkrug, J., Gozes, I., Laburthe, M., May, V., Pisegna, J. R., Vaudry, D., Vaudry, H., Waschek, J. A., & Said, S. I. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01871.x · Cited by 471
Self-citationBuzzi, M. G., & Moskowitz, M. A. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb14679.x · Cited by 416
Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics
Iversen, H. K., Olesen, J., & Tfelt-Hansen, P. (1989) · Pain · doi:10.1016/0304-3959(89)90067-5 · Cited by 381
Self-citationMast cell degranulation activates a pain pathway underlying migraine headache
Levy, D., Burstein, R., Kainz, V., Jakubowski, M., & Strassman, A. M. (2007) · Pain · doi:10.1016/j.pain.2007.03.012 · Cited by 371
Evidence for a vascular factor in migraine
Asghar, M. S., Hansen, A. E., Amin, F. M., van der Geest, R. J., Koning, P. V. D., Larsson, H. B. W., Olesen, J., & Ashina, M. (2011) · Annals of Neurology · doi:10.1002/ana.22292 · Cited by 309
Self-citationAmin, F. M., Asghar, M. S., Hougaard, A., Hansen, A. E., Larsen, V. A., de Koning, P. J., Larsson, H. B., Olesen, J., & Ashina, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70067-x · Cited by 295
Self-citationLevy, D., Jakubowski, M., & Burstein, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306147101 · Cited by 257
Vasoactive Intestinal Peptide Causes Marked Cephalic Vasodilation, but does not Induce Migraine
Rahmann, A., Wienecke, T., Hansen, J., Fahrenkrug, J., Olesen, J., & Ashina, M. (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01497.x · Cited by 257
Self-citationSchoonman, G. G., van der Grond, J., Kortmann, C., van der Geest, R. J., Terwindt, G. M., & Ferrari, M. D. (2008) · Brain · doi:10.1093/brain/awn094 · Cited by 239
Tuka, B., Helyes, Z., Markovics, A., Bagoly, T., Szolcsányi, J., Szabó, N., Tóth, E., Kincses, Z. T., Vécsei, L., & Tajti, J. (2013) · Cephalalgia · doi:10.1177/0333102413483931 · Cited by 231
Messenger molecules and receptor mRNA in the human trigeminal ganglion
Tajti, J., Uddman, R., Möller, S., Sundler, F., & Edvinsson, L. (1999) · Journal of the Autonomic Nervous System · doi:10.1016/s0165-1838(99)00024-7 · Cited by 205
Clinical Benefits of Early Triptan Therapy for Migraine
Láinez, M. (2004) · Cephalalgia · doi:10.1111/j.1468-2982.2004.00895.x · Cited by 181
Markers of Mast Cell Degranulation
Hogan, A. D., & Schwartz, L. B. (1997) · Methods · doi:10.1006/meth.1997.0494 · Cited by 178
(1964) · Neurology · doi:10.1212/wnl.14.2.163 · Cited by 178
VIP and PACAP: very important in pain?
Dickinson, T., & Fleetwood-Walker, S. M. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01340-1 · Cited by 147
Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers
Amin, F. M., Asghar, M. S., Guo, S., Hougaard, A., Hansen, A. E., Schytz, H. W., van der Geest, R. J., de Koning, P. J., Larsson, H. B. W., Olesen, J., et al. (2011) · Cephalalgia · doi:10.1177/0333102411431333 · Cited by 133
Self-citationDural mast cell degranulation is a putative mechanism for headache induced by PACAP-38
Baun, M., Pedersen, M. H. F., Olesen, J., & Jansen‐Olesen, I. (2012) · Cephalalgia · doi:10.1177/0333102412439354 · Cited by 130
Self-citationUddman, R., Tajti, J., Hou, M., Sundler, F., & Edvinsson, L. I. (2002) · Cephalalgia · doi:10.1046/j.1468-2982.2002.00324.x · Cited by 119
Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia
Knutsson, M., & Edvinsson, L. I. (2002) · Neuroreport · doi:10.1097/00001756-200203250-00030 · Cited by 92
Fahrenkrug, J., Hannibal, J., Tams, J. W., & Georg, B. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200008000-00006 · Cited by 82
Self-citationHomeodomain Protein Otp and Activity-Dependent Splicing Modulate Neuronal Adaptation to Stress
Amir-Zilberstein, L., Blechman, J., Sztainberg, Y., Norton, W., Reuveny, A., Borodovsky, N., Tahor, M., Bonkowsky, J. L., Bally‐Cuif, L., Chen, A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.019 · Cited by 76
Boni, L., Ploug, K. B., Olesen, I. J., Jansen‐Olesen, I., & Gupta, S. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01807.x · Cited by 76
Markedly reduced chronic nociceptive response in mice lacking the PAC1 receptor
Jongsma, H., Pettersson, L. M. E., Zhang, Y., Reimer, M. K., Kanje, M., Waldenström, A., Sundler, F., & Danielsen, N. (2001) · Neuroreport · doi:10.1097/00001756-200107200-00034 · Cited by 72
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)
Mustafa, T. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-411512-5.00021-x · Cited by 69
Resch, J. M., Maunze, B., Gerhardt, A. K., Magnuson, S. K., Phillips, K. A., & Choi, S. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00293.2013 · Cited by 62
Montelukast for Migraine Prophylaxis: A Randomized, Double‐Blind, Placebo‐Controlled Study
Brandes, J. L., Visser, W. H., Farmer, M. V., Schuhl, A. L., Malbecq, W., Vrijens, F., Lines, C. R., Reines, S. A., & Protocol 125 study group (2004) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2004.446006.x · Cited by 46
Baun, M., Hay‐Schmidt, A., Edvinsson, L. I., Olesen, J., & Jansen‐Olesen, I. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.08.016 · Cited by 43
Self-citationEffect of Adrenomedullin on the Cerebral Circulation: Relevance to Primary Headache Disorders
Petersen, K. A., Birk, S., Kitamura, K., & Olesen, J. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01695.x · Cited by 42
Self-citationGrände, G., Nilsson, E., & Edvinsson, L. I. (2012) · Cephalalgia · doi:10.1177/0333102412468340 · Cited by 31
PACAP modulates GnRH signaling in gonadotropes
Halvorson, L. M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.09.029 · Cited by 30
Taylor, R. D. T., Madsen, M. G., Krause, M., Castañeda, M. S., Stocker, M., & Pedarzani, P. (2013) · Hippocampus · doi:10.1002/hipo.22201 · Cited by 22
Mustafa, T., Stroth, N., Lehmann, M. L., Chan, S., Smith, C. B., & Eiden, L. E. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-800044-1.00216-6 · Cited by 10
GATA augments GNRH-mediated increases in Adcyap1 gene expression in pituitary gonadotrope cells
Thomas, R. L., Crawford, N., Grafer, C. M., Zheng, W., & Halvorson, L. M. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0089 · Cited by 9
Maejima, Y., Shimomura, K., Sakuma, K., Yang, Y. K., Arai, T., Mori, M., & Yada, T. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.07.006 · Cited by 5
Cited by
Pathophysiology of migraine: a disorder of sensory processing
Goadsby, P. J., Holland, P. R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., & Akerman, S. (2017) · Physiological Reviews · doi:10.1152/physrev.00034.2015 · Cited by 1,998
The pathophysiology of migraine: implications for clinical management
Charles, A. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30435-0 · Cited by 644
A Phase‐by‐Phase Review of Migraine Pathophysiology
Dodick, D. W. (2018) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13300 · Cited by 505
Ferrari, M. D., Goadsby, P. J., Burstein, R., Kurth, T., Ayata, C., Charles, A., Ashina, M., van den Maagdenberg, A. M. J. M., & Dodick, D. W. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00328-4 · Cited by 500
Self-citationMigraine: disease characterisation, biomarkers, and precision medicine
Ashina, M., Terwindt, G. M., Al-Karagholi, M. A.-M., de Boer, I., Lee, M. J., Hay, D. L., Schulte, L. H., Hadjikhani, N., Sinclair, A. J., Ashina, H., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32162-0 · Cited by 381
Self-citation
Metadata
- Authors
- Amin, F. M., Hougaard, A., Schytz, H. W., Asghar, M. S., Lundholm, E., Parvaiz, A. I., de Koning, P. J. H., Andersen, M. R., Larsson, H. B. W., Fahrenkrug, J., Olesen, J., & Ashina, M.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-02-05
- Volume
- 137
- Issue
- 3
- Pages
- 779-794
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2117743525
- Cited by
- 262
- References
- 44
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.